Form 13-F position report

EYEGATE PHARMACEUTICALS INC

Reported by IFP Advisors Inc

KPHMW CUSIP 30233M107 Manager CIK 0001641866

Reported 0 shares, down 26,800 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2018
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 3 Through Q3 2018

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for EYEGATE PHARMACEUTICALS INC held by IFP Advisors Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

25 managers reported EYEGATE PHARMACEUTICALS INC for Q3 2018.

Managers reporting EYEGATE PHARMACEUTICALS INC in Q3 2018.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ARMISTICE CAPITAL LLC Unchanged 16,802,500 0 0.31% $5,209,000 6 qtrs
VANGUARD GROUP INC Added 115,410 +461 < 0.01% $36,000 12 qtrs
PANAGORA ASSET MANAGEMENT INC New 107,430 +107,430 < 0.01% $33,000 1 qtr
ACADIAN ASSET MANAGEMENT LLC New 76,023 +76,023 < 0.01% $24,000 3 qtrs
Barclays PLC Added 74,595 +9,095 < 0.01% $23,000 3 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP New 69,819 +69,819 < 0.01% $22,000 1 qtr
TWO SIGMA SECURITIES LLC New 55,855 +55,855 < 0.01% $17,000 7 qtrs
MILLENNIUM MANAGEMENT LLC New 44,270 +44,270 < 0.01% $14,000 1 qtr
US BANCORP DE Unchanged 40,650 0 < 0.01% $13,000 3 qtrs
CITADEL ADVISORS LLC Added 35,492 +9,641 < 0.01% $11,000 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2018
Filed
October 25, 2018
Filing type
13F-HR
Position type
Stock

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.